Atorvastatin Calcium Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition
Atorvastatin Calcium Price Trend, Index and Forecast
Track the latest insights on atorvastatin calcium price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Atorvastatin Calcium Prices Outlook Q3 2026
- India: USD 92,310/MT
- Indonesia: USD 90,464/MT
- China: USD 89,541/MT
- USA: USD 97,849/MT
- Canada: USD 98,827/MT
Atorvastatin Calcium Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2026, the atorvastatin calcium prices in India reached 92,310 USD/MT in September. Prices eased as downstream pharmaceutical formulation manufacturers absorbed the volumes offered to the domestic market. Firm operating rates at domestic API synthesis plants kept the volume of ready material limited for buyers placing immediate inquiries. Competitive feedstock economics and steady generic tablet output sustained demand for bulk atorvastatin calcium API material through the period.
During the third quarter of 2026, the atorvastatin calcium prices in Indonesia reached 90,464 USD/MT in September. Prices moved lower as downstream pharmaceutical manufacturers absorbed the volumes offered to the market. Import dependent buyers faced firmer replacement costs on cargoes sourced from established supplying origins through the quarter. Port handling and inland freight charges on imported material added to landed values at the main entry points.
During the third quarter of 2026, the atorvastatin calcium prices in China reached 89,541 USD/MT in September. Prices softened as downstream tablet and finished dosage form manufacturers absorbed the volumes offered to the domestic market. Firm operating rates at domestic API production facilities kept the volume of ready material limited for buyers placing immediate inquiries. Competitive manufacturing economics and expanding generic pharmaceutical output underpinned steady demand for bulk atorvastatin calcium through the period.
During the third quarter of 2026, the atorvastatin calcium prices in the USA reached 97,849 USD/MT in September. Prices advanced as downstream pharmaceutical manufacturers absorbed the volumes offered to the domestic market. Firm operating rates at domestic API synthesis plants kept the volume of ready material limited for buyers placing immediate inquiries. Firmer precursor costs and rising statin prescription volumes across cardiovascular therapy end uses supported the upward price direction through the quarter.
During the third quarter of 2026, the atorvastatin calcium prices in Canada reached 98,827 USD/MT in September. Prices climbed as downstream formulation manufacturers absorbed the volumes offered to the market. Import dependent buyers faced firmer replacement costs on cargoes sourced from established supplying origins through the quarter. Port handling and inland freight charges on imported material added to landed values at the main entry points.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing atorvastatin calcium prices.
Europe Atorvastatin Calcium Price Trend
Q3 2026:
The atorvastatin calcium market in Europe is primarily shaped by regional import dependency and downstream industrial demand across tablet formulation, cardiovascular disease management, and cholesterol-lowering medication supply chains. However, due to logistics constraints and varying regulatory regimes, atorvastatin calcium prices might fluctuate dynamically across the region.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Atorvastatin Calcium Price Trend
Q3 2026:
The atorvastatin calcium price index in North America moved upward during the quarter, shaped by firm downstream demand and steady API production activity across the region. The USA, the principal producing and consuming market, saw pharmaceutical formulation plants record active procurement of available volumes. Firm operating rates at domestic API synthesis plants kept the volume of prompt material limited for buyers placing immediate inquiries. Firmer replacement costs on key synthesis precursors raised the cost of stock held by traders and distributors serving the domestic market. Buyers across the region depend on a mix of local output and imported parcels, so freight and inland logistics charges added to delivered costs. Steady demand from statin-based cardiovascular therapy, cholesterol management programs, and combination tablet manufacture remained supportive of underlying consumption.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Atorvastatin Calcium Price Trend
Q3 2026:
The study includes atorvastatin calcium price trends across the Middle East and Africa, taking into consideration variables that have a direct impact on market prices, such as regional industrial expansion, natural resource availability, and geopolitical conflicts.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia-Pacific Atorvastatin Calcium Price Trend
Q3 2026:
The atorvastatin calcium price index in Asia-Pacific moved lower through the quarter, reflecting easing market conditions and steady trade flows across the region. China, a major producing and consuming market, recorded softer values as pharmaceutical tablet and finished dosage form manufacturers maintained active procurement of available material. India followed a similar pattern, with generic formulation manufacturers absorbing the volumes offered to the market. Regional buyers depend on a mix of domestic API production capacity and imported parcels, so replacement costs and inbound freight shaped landed values. Firm operating rates at regional API synthesis facilities kept the volume of prompt material limited for buyers outside contract arrangements. Export inquiries from overseas pharmaceutical manufacturers also reduced the volume of material offered into domestic spot markets.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Atorvastatin Calcium Price Trend
Q3 2026:
The atorvastatin calcium market in Latin America is primarily shaped by regional import dependency and downstream industrial demand across tablet formulation, cardiovascular disease management, and cholesterol-lowering medication supply chains. However, due to logistics constraints and varying regulatory regimes, atorvastatin calcium prices might fluctuate dynamically across the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Atorvastatin Calcium Pricing Report, Market Analysis, and News
IMARC's latest publication, "Atorvastatin Calcium Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition," presents a detailed examination of the atorvastatin calcium market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of atorvastatin calcium at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed atorvastatin calcium prices trend analysis by region, covering North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. The factors affecting atorvastatin calcium pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Atorvastatin Calcium Industry Analysis
The global atorvastatin calcium market was valued at USD 15.8 Billion in 2025. By 2034, IMARC Group expects the market to reach USD 35.3 Billion, at a projected CAGR of 9.37% during 2026-2034. Market growth is being driven by the rising global burden of cardiovascular diseases and increasing statin prescription rates for primary and secondary prevention, the expanding generic pharmaceutical market and ongoing patent expirations enabling broader API competition across major markets, and growing demand from pharmaceutical manufacturers in emerging economies seeking cost-effective cholesterol-lowering therapies for treatment of hyperlipidemia and dyslipidemia.
Latest News and Developments:
- May 2025: Alembic Pharmaceuticals Limited received final approval from the US Food and Drug Administration for its Abbreviated New Drug Application for Amlodipine and Atorvastatin Tablets USP across eleven strength combinations, covering doses ranging from 2.5 mg/10 mg to 10 mg/80 mg. This accomplishment highlights the firm's increasing role in the pharmaceutical sector, especially in the generics field, where securing ANDA approvals is essential for broadening product offerings and improving market competitiveness.
Product Description
Atorvastatin calcium is a synthetic statin belonging to the HMG-CoA reductase inhibitor class, commercially available in trihydrate and other crystalline salt forms. At ambient conditions it presents as a white to off-white crystalline powder with low water solubility, negligible dour, and sensitivity to moisture. The compound inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-limiting enzyme in hepatic cholesterol biosynthesis, and is one of the most widely prescribed active pharmaceutical ingredients globally. Principal end-use sectors include cardiovascular pharmaceutical formulations for hypercholesterolemia and mixed dyslipidemia management, primary and secondary prevention of cardiovascular events, combination therapy with antihypertensive agents such as amlodipine, and pediatric familial hypercholesterolemia treatment.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Atorvastatin Calcium |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Atorvastatin Calcium Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of atorvastatin calcium pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting atorvastatin calcium price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The atorvastatin calcium price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: [email protected]
Client Testimonials
.webp)
.webp){kind=logo}
Related Reports
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.